Lung Function Decline and Airflow Limitation Risk in Preserved Ratio Impaired Spirometry Subtypes by Smoking Status
CHEST · 2025
DOI: 10.1016/j.chest.2025.05.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift CHEST, 2025. Verfasst von Cuiqiong Dai und 22 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease & Guangzhou Institute of Respiratory Health &…. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Smoking, Lung. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Guangzhou Medical University, Guangzhou Municipal Science and Technology Project, State Key Laboratory of Respiratory Disease.
Abstract (Originalsprache)
BACKGROUND: Preserved ratio impaired spirometry (PRISm) is regarded as a COPD precursor, but whether this varies by smoking status remains unclear. RESEARCH QUESTION: Are annual lung function decline and the risk of developing airflow limitation different among PRISm subtypes by smoking status? STUDY DESIGN AND METHODS: A total of 2,850 participants from a 15-year population-based prospective cohort were included in this analysis. Participants were categorized into 3 groups: patients with normal spirometry who do not smoke (normal control), patients with PRISm who do not smoke (NS-PRISm), and patients with PRISm who have ever smoked (ES-PRISm). We compared annual lung function decline and the risk of developing airflow limitation among the 3 groups. RESULTS: Participants in the normal control group exhibited the fastest decline in annual lung function, followed by the ES-PRISm group, with the NS-PRISm group showing the slowest decline. Participants in the ES-PRISm group had significantly faster annual lung function decline than the NS-PRISm group. Participants in the ES-PRISm group had a significantly increased risk of developing airflow limitation than the NS-PRISm group (95 of 256 [37.1%] vs 69 of 470 [14.7%]; adjusted hazard ratio [HR], 1.90; 95% CI, 1.31-2.77; P = .001) and normal control group (95 of 256 [37.1%] vs 193 of 2,124 [9.1%]; adjusted HR, 2.69; 95% CI, 1.96-3.69; P < .001). Participants in the NS-PRISm group also exhibited a higher risk of developing airflow limitation than those in the normal control group (69 of 470 [14.7%] vs 193 of 2,124 [9.1%]; adjusted HR, 1.41; 95% CI, 1.07-1.87; P = .016). When the ES-PRISm group was further divided into participants with PRISm who currently smoke and those who formerly smoked, both of these PRISm subtypes showed a faster annual lung function decline and a similarly higher risk of airflow limitation than the NS-PRISm group. INTERPRETATION: These findings suggest that both NS-PRISm and ES-PRISm may be potential precursors to COPD and indicate that PRISm should not be restricted to evaluating individuals with a history of smoking alone.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease & Guangzhou Institute of Respiratory Health & National Center for Respiratory Medicine & Department of Pulmonary an…
- Department of Pulmonary and Critical Care Medicine, The Second People's Hospital of Hunan Province, Changsha, Hunan, China.
- Department of Pulmonary and Critical Care Medicine, Wengyuan County People's Hospital, Shaoguan, Guangdong, China.
- Lianping County People's Hospital, Lianping County Hospital of Traditional Chinese Medicine, Heyuan, Guangdong, China.
- Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China.
- The Second Hospital of Liwan District of Guangzhou, Guangzhou, Guangdong, China.
Förderung
- Guangzhou Medical University
- Guangzhou Municipal Science and Technology Project
- State Key Laboratory of Respiratory Disease
Zitieren
APA
Dai, C., Wu, F., Tian, J., Cui, J., Deng, Z., Tian, H., Huang, P., Yang, H., Zheng, Y., Wang, Z., Xiao, S., Wen, X., Lu, L., Zhao, N., Yang, C., Yu, S., Liu, S., Wang, D., Wang, X., …, & Ran, P. (2025). Lung Function Decline and Airflow Limitation Risk in Preserved Ratio Impaired Spirometry Subtypes by Smoking Status. CHEST. https://doi.org/10.1016/j.chest.2025.05.006
Vancouver
Dai C, Wu F, Tian J, Cui J, Deng Z, Tian H, et al. Lung Function Decline and Airflow Limitation Risk in Preserved Ratio Impaired Spirometry Subtypes by Smoking Status. CHEST. 2025. doi:10.1016/j.chest.2025.05.006
BibTeX
@article{Dai2025,
author = {Dai, Cuiqiong and Wu, Fan and Tian, Jia and Cui, Jiangyu and Deng, Zhishan and Tian, Heshen and Huang, Peiyu and Yang, Huajing and Zheng, Youlan and Wang, Zihui and Xiao, Shan and Wen, Xiang and Lu, Lifei and Zhao, Ningning and Yang, Changli and Yu, Shuqing and Liu, Shengming and Wang, Dali and Wang, Xiaoping and Lv, Jiachun and Zhong, Nanshan and Zhou, Yumin and Ran, Pixin},
title = {Lung Function Decline and Airflow Limitation Risk in Preserved Ratio Impaired Spirometry Subtypes by Smoking Status},
journal = {CHEST},
year = {2025},
doi = {10.1016/j.chest.2025.05.006}
}
EUVIMED